Recently, a retrospective cohort study in breast cancer patients demonstrated that high tumor THRα1 expression was associated with shorter 5-year survival, particularly when the expression of ‘favorable’ THRα2 was concomitantly low23. This evidence concerns the gene THRA and neoplasm.